tiprankstipranks
Trending News
More News >
Newmed Energy Limited Partnership (IL:NWMD)
:NWMD
Advertisement

Newmed Energ Pu (NWMD) AI Stock Analysis

Compare
3 Followers

Top Page

IL:NWMD

Newmed Energ Pu

(OTC:NWMD)

Select Model
Select Model
Select Model
Outperform 79 (OpenAI - 4o)
Rating:79Outperform
Price Target:
1,832.00
▲(4.09% Upside)
Newmed Energ Pu's strong financial performance, characterized by robust profitability and cash flow, is a key strength. The stock's technical indicators suggest a bullish trend, supported by attractive valuation metrics. These factors collectively contribute to a favorable overall stock score.

Newmed Energ Pu (NWMD) vs. iShares MSCI Israel ETF (EIS)

Newmed Energ Pu Business Overview & Revenue Model

Company DescriptionNewmed Energ Pu (NWMD) is a company operating in the energy sector, focusing on the development and production of natural gas resources. It is involved in the exploration, extraction, and distribution of natural gas, serving various markets with a commitment to sustainable and efficient energy solutions.
How the Company Makes MoneyNewmed Energ Pu generates revenue primarily through the sale of natural gas. The company engages in long-term contracts with industrial, commercial, and residential clients to supply natural gas. Its revenue model includes direct sales, distribution partnerships, and infrastructure investments that ensure efficient delivery of natural gas to its customers. Additionally, Newmed Energ Pu may enter into joint ventures with other energy companies to optimize resource extraction and distribution, further enhancing its revenue streams. The company's earnings are significantly influenced by global gas prices, regulatory environments, and its ability to maintain strong relationships with key stakeholders in the energy market.

Newmed Energ Pu Financial Statement Overview

Summary
Newmed Energ Pu demonstrates strong profitability with high gross and net profit margins, indicating efficient cost management. Despite a recent decline in TTM revenue, the company maintains robust EBIT and EBITDA margins, reflecting operational efficiency. The balance sheet shows improved leverage management, and cash flow is healthy with positive free cash flow growth.
Income Statement
75
Positive
Newmed Energ Pu demonstrates strong profitability with high gross and net profit margins, indicating efficient cost management. However, the recent TTM revenue shows a decline, which could be a concern if the trend continues. Despite this, the company maintains robust EBIT and EBITDA margins, reflecting operational efficiency.
Balance Sheet
70
Positive
The company has improved its debt-to-equity ratio over recent periods, indicating better leverage management. Return on equity remains strong, showcasing effective use of equity to generate profits. However, the equity ratio suggests moderate reliance on debt, which could pose risks if market conditions worsen.
Cash Flow
80
Positive
Newmed Energ Pu shows a healthy cash flow position with positive free cash flow growth and a strong operating cash flow to net income ratio. The company effectively converts its earnings into cash, which supports its financial flexibility and ability to invest in growth opportunities.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue1.06B1.14B934.60M1.14B882.50M587.10M
Gross Profit664.80M718.10M780.70M701.70M518.11M535.48M
EBITDA783.30M874.80M782.70M872.10M633.90M454.00M
Net Income464.10M524.60M433.60M469.70M404.90M365.30M
Balance Sheet
Total Assets3.96B3.99B3.85B3.94B3.85B4.58B
Cash, Cash Equivalents and Short-Term Investments388.40M384.50M186.70M418.30M340.85M239.35M
Total Debt1.52B1.63B1.82B2.16B2.22B3.25B
Total Liabilities2.09B2.21B2.33B2.65B2.91B3.59B
Stockholders Equity1.86B1.79B1.51B1.29B938.54M997.70M
Cash Flow
Free Cash Flow535.60M463.30M423.10M405.80M423.25M163.59M
Operating Cash Flow681.40M577.50M559.50M504.70M453.64M328.68M
Investing Cash Flow55.20M-114.20M36.10M-273.50M982.04M-241.82M
Financing Cash Flow-467.40M-441.20M-588.90M-429.10M-1.29B-187.92M

Newmed Energ Pu Technical Analysis

Technical Analysis Sentiment
Positive
Last Price1760.00
Price Trends
50DMA
1581.30
Positive
100DMA
1545.07
Positive
200DMA
1387.13
Positive
Market Momentum
MACD
30.50
Negative
RSI
70.37
Negative
STOCH
94.81
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IL:NWMD, the sentiment is Positive. The current price of 1760 is above the 20-day moving average (MA) of 1620.45, above the 50-day MA of 1581.30, and above the 200-day MA of 1387.13, indicating a bullish trend. The MACD of 30.50 indicates Negative momentum. The RSI at 70.37 is Negative, neither overbought nor oversold. The STOCH value of 94.81 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IL:NWMD.

Newmed Energ Pu Peers Comparison

Overall Rating
UnderperformOutperform
Sector (65)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
79
Outperform
$20.47B12.0526.44%4.23%-7.79%-4.84%
79
Outperform
3.63B20.866.08%11.84%-4.96%
77
Outperform
5.11B10.6128.23%8.54%
71
Outperform
$14.64B15.7110.26%6.65%18.62%-18.29%
65
Neutral
$15.17B7.614.09%5.20%3.87%-62.32%
45
Neutral
13.06B252.65-26.31%-655.28%
* Energy Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IL:NWMD
Newmed Energ Pu
1,760.00
809.93
85.25%
IL:DLEKG
Delek Group
82,850.00
43,209.49
109.00%
IL:ISRA
Isramco Pu
240.20
93.35
63.57%
IL:RATI
Ratio Pu
464.30
199.42
75.29%
IL:TMRP
Tamar Pet
4,573.00
2,681.01
141.70%
IL:NVPT
Navitas Ptro Pu
11,050.00
5,509.00
99.42%

Newmed Energ Pu Corporate Events

Newmed Energ Pu Withdraws Class Action in Settlement with Chevron
Feb 18, 2025

Newmed Energ Pu announced the withdrawal of a class action lawsuit against Chevron Mediterranean Limited, as part of a broader settlement negotiation. The agreement, reached with mutual consent, was filed with authorities and includes scheduled hearings to ensure compliance and implementation of the terms. The companies will continue collaborative efforts to resolve outstanding issues and maintain shareholder updates following key hearings.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 20, 2025